160 related articles for article (PubMed ID: 3080935)
1. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.
Jordan RA; Seth L; Casebolt P; Hayes MJ; Wilen MM; Franciosa J
Ann Intern Med; 1986 Mar; 104(3):295-8. PubMed ID: 3080935
[TBL] [Abstract][Full Text] [Related]
2. Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
Jordan RA; Seith L; Henry DA; Wilen MM; Franciosa JA
Circulation; 1985 May; 71(5):980-6. PubMed ID: 3921279
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
[TBL] [Abstract][Full Text] [Related]
4. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.
Sharpe N; Coxon R; Webster M; Luke R
Am J Cardiol; 1987 Apr; 59(8):895-9. PubMed ID: 3103412
[TBL] [Abstract][Full Text] [Related]
6. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.
Elkayam U; Kulick D; McIntosh N; Roth A; Hsueh W; Rahimtoola SH
Circulation; 1987 Sep; 76(3):577-84. PubMed ID: 3113764
[TBL] [Abstract][Full Text] [Related]
7. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
Roth A; Kulick D; Freidenberger L; Hong R; Rahimtoola SH; Elkayam U
J Am Coll Cardiol; 1987 Apr; 9(4):858-64. PubMed ID: 3104435
[TBL] [Abstract][Full Text] [Related]
8. Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure.
Bolognese L; Sarasso G; Rognoni G; Makmur J; Fornaro G; Perucca A; Rossi P
Clin Cardiol; 1988 Feb; 11(2):79-85. PubMed ID: 3126012
[TBL] [Abstract][Full Text] [Related]
9. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
[TBL] [Abstract][Full Text] [Related]
10. [The advantageous effects of a prolonged intravenous load with a nitroglycerin solution on the lesser circulation in patients with chronic heart failure].
Kazeĭ DV; Mareev VIu
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):27-34. PubMed ID: 3148308
[TBL] [Abstract][Full Text] [Related]
11. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
Mikulic E; Franciosa JA; Cohn JN
Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
[TBL] [Abstract][Full Text] [Related]
12. Nitrate tolerance in heart failure: differential venous, pulmonary and systemic arterial effects.
Makhoul N; Dakak N; Flugelman MY; Merdler A; Shefer A; Schneeweiss A; Halon DA; Lewis BS
Am J Cardiol; 1990 Jun; 65(21):28J-31J. PubMed ID: 2112336
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
Elkayam U; Akhter MW; Singh H; Khan S; Usman A
Am J Cardiol; 2004 Jan; 93(2):237-40. PubMed ID: 14715359
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
Armstrong PW
J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
[TBL] [Abstract][Full Text] [Related]
15. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
[TBL] [Abstract][Full Text] [Related]
16. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
[No Abstract] [Full Text] [Related]
17. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
Packer M; Medina N; Yushak M; Lee WH
Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.
Olivari MT; Carlyle PF; Levine TB; Cohn JN
J Am Coll Cardiol; 1983 Nov; 2(5):872-8. PubMed ID: 6415142
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of nitroglycerin ointment in congestive heart failure.
Taylor WR; Forrester JS; Magnusson P; Takano T; Chatterjee K; Swan HJ
Am J Cardiol; 1976 Oct; 38(4):469-73. PubMed ID: 823808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
